Recent conference presentations

Occupational Health 2024

Belfast, UK

• Making it Work™ - Scotland: Adapting a Canadian programme to support people working with musculoskeletal (MSK) conditions in the UK 
  Cara Ghiglieri, R Stuart Anderson, Elaine Wainwright, Rosemary Hollick, Diane Lacaille, Gary Macfarlane and LaKrista Morton
  
  

British Pain Society Annual Scientific Meeting 2024

Nottingham, UK

• Population-Level Association between Physical Activity and High Impact Chronic Pain 10 Years Later
  Marcus Beasley, Elaine Wainwright and Gary Macfarlane on behalf of the CHIPP Investigators and Patient Research Partners
  
  
   

International Congress on Occupational Health (ICOH) 2024

Marrakesh, Morocco

• QUantifying the Impact of Chronic pain on worK (QUICK)
  LaKrista Morton, Martin J Stevens, Elaine Wainwright, R Stuart Anderson, Ira Madan, Nicola Fear, Suzanne Verstappen, Paul McNamee, Anne Stagg, Nicola Goodson, Karen Walker-Bone, Rosemary J Hollick, Gary J Macfarlane
  
  

British Society for Rheumatology (BSR) Annual Conference 2024

Liverpool, UK

• Geographical variaions in delivery of intravenous treatment for ANCA-associated vasculitis
  Warren James, Avril Nicoll, Louise Locock, Lorrain Harper, Mark A Little, Neil Basu, Rosemary Hollick
  
  
  
  In this poster presentation from the British Society for Rheumatology Annual Conference 2024, Dr Rosemary Hollick discusses access to intravenous (IV) immunosuppressant therapy for ANCA-associated vasculitis (AAV) across the UK and Ireland.
   
• Measuring social engagement in rheumatic and musculoskeletal diseases
  Alison MacIver, Gary Macfarlane, Rosemary Hollick
  
  
  
  In this poster presentation from the British Society for Rheumatology Annual Meeting 2023, Alison MacIver of the University of Aberdeen evaluate the existing measures of social engagement used in rheumatic and musculoskeletal disease (RMD) populations.

British Society for Antimicrobial Chemotherapy (BSAC) Winter Conference 2023

London, UK

• UK Antimicrobial Registry (UKAR) Study: Progress to date
  Rebecca Parr, Jay Woods, Gareth T Jones, Gary J Macfarlane, Jacqueline Sneddon and Laura J Moir
  
  Poster designed by Christien Quilay
  
  

American College of Rheumatology - ACR Convergence 2023

San Diego, USA

• The influence of “fibromyalgia-ness” on treatment response amongst patients with Psoriatic Arthritis (PsA). Results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR‐PsA)
  Gary J Macfarlane, Ovidiu Rotariu, Stephanie Lembke, Flavia Sunzini, Gareth T Jones and Neil Basu (on behalf of CENTAUR investigators)
  
  
   
• Using a Whole-population Approach to Help Design More Effective and Efficient Healthcare Services for People with Fibromyalgia
  Gary J Macfarlane, Roxanne Cooksey, Ernest Choy and Rosemary Hollick (on behalf of PACFiND investigators)
  
  

British Society for Spondyloarthritis (BRITSpA) Annual Scientific Meeting 2023

Warwrickshire, UK

• Two-thirds patients with axSpA are already beyond ‘early’ disease by the time they receive a diagnosis – data from the BSRBR-AS
  Gareth T Jones, Gary J Macfarlane and Ovidiu Rotariu
  
  
   
• In an age of artificial intelligence, it’s possible to produce fake but very convincing scientific abstracts, quickly and easily
  Gareth T Jones and Nicola J Goodson
  
  

Health Services UK Conference 2023

Birmingham, UK

• Moving beyond aspirational rhetoric – learning from the role of professional jurisdictions in integrated care delivery in rare disease
  Rosemary Hollick
  
  
  
  This research is from the Vasculitis Outcomes In relation to Care ExperienceS (VOICES) study. You can find out more about VOICES at our study webpages.

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Annual Meeting 2023

Dublin, Ireland

• Treatment response in PsA: Sleep, disease duration, skin and nail disease matter
  Stephanie Lembke, Ovidiu Rotariu, Ross MacDonald, Rosemary J Hollick, Gary J Macfarlane and Gareth T Jones